A citation-based method for searching scientific literature

Valerie A Flores, Lubna Pal, JoAnn E Manson. Endocr Rev 2021
Times Cited: 3







List of co-cited articles
19 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging.
Siobán D Harlow, Margery Gass, Janet E Hall, Roger Lobo, Pauline Maki, Robert W Rebar, Sherry Sherman, Patrick M Sluss, Tobie J de Villiers. Fertil Steril 2012
94
66

Premature ovarian insufficiency: A toolkit for the primary care physician.
Irene Lambrinoudaki, Stavroula A Paschou, Mary Ann Lumsden, Stephanie Faubion, Evangelos Makrakis, Sophia Kalantaridou, Nick Panay. Maturitas 2021
7
66

EMAS clinical guide: selective estrogen receptor modulators for postmenopausal osteoporosis.
Santiago Palacios, Mark Brincat, C Tamer Erel, Marco Gambacciani, Irene Lambrinoudaki, Mette H Moen, Karin Schenck-Gustafsson, Florence Tremollieres, Svetlana Vujovic, Margaret Rees,[...]. Maturitas 2012
16
66

The British Menopause Society & Women's Health Concern 2020 recommendations on hormone replacement therapy in menopausal women.
Haitham Hamoda, Nick Panay, Hugo Pedder, Roopen Arya, Mike Savvas. Post Reprod Health 2020
28
66

Maintaining postreproductive health: A care pathway from the European Menopause and Andropause Society (EMAS).
Eleni Armeni, Irene Lambrinoudaki, Iuliana Ceausu, Herman Depypere, Alfred Mueck, Faustino R Pérez-López, Yvonne T van der Schouw, Levent M Senturk, Tommaso Simoncini, John C Stevenson,[...]. Maturitas 2016
48
66

Safety and efficacy of testosterone for women: a systematic review and meta-analysis of randomised controlled trial data.
Rakibul M Islam, Robin J Bell, Sally Green, Matthew J Page, Susan R Davis. Lancet Diabetes Endocrinol 2019
74
66

ESHRE Guideline: management of women with premature ovarian insufficiency.
L Webber, M Davies, R Anderson, J Bartlett, D Braat, B Cartwright, R Cifkova, S de Muinck Keizer-Schrama, E Hogervorst, F Janse,[...]. Hum Reprod 2016
496
66

Topical estrogens and non-hormonal preparations for postmenopausal vulvovaginal atrophy: An EMAS clinical guide.
Angelica Lindén Hirschberg, Johannes Bitzer, Antonio Cano, Iuliana Ceausu, Peter Chedraui, Fatih Durmusoglu, Risto Erkkola, Dimitrios G Goulis, Ludwig Kiesel, Patrice Lopes,[...]. Maturitas 2021
10
66


EMAS position statement: Managing women with premature ovarian failure.
Svetlana Vujovic, Marc Brincat, Tamer Erel, Marco Gambacciani, Irene Lambrinoudaki, Mette H Moen, Karin Schenck-Gustafsson, Florence Tremollieres, Serge Rozenberg, Margaret Rees. Maturitas 2010
79
66


Menopause and diabetes: EMAS clinical guide.
Radoslaw Slopien, Ewa Wender-Ozegowska, Anita Rogowicz-Frontczak, Blazej Meczekalski, Dorota Zozulinska-Ziolkiewicz, Jesse D Jaremek, Antonio Cano, Peter Chedraui, Dimitrios G Goulis, Patrice Lopes,[...]. Maturitas 2018
47
66


Is there a role for menopausal hormone therapy in the management of postmenopausal osteoporosis?
S Rozenberg, N Al-Daghri, M Aubertin-Leheudre, M-L Brandi, A Cano, P Collins, C Cooper, A R Genazzani, T Hillard, J A Kanis,[...]. Osteoporos Int 2020
25
66

Menopause symptom management in women with dyslipidemias: An EMAS clinical guide.
Panagiotis Anagnostis, Johannes Bitzer, Antonio Cano, Iuliana Ceausu, Peter Chedraui, Fatih Durmusoglu, Risto Erkkola, Dimitrios G Goulis, Angelica Lindén Hirschberg, Ludwig Kiesel,[...]. Maturitas 2020
19
66


Short-term and long-term effects of tibolone in postmenopausal women.
Giulio Formoso, Enrica Perrone, Susanna Maltoni, Sara Balduzzi, Jack Wilkinson, Vittorio Basevi, Anna Maria Marata, Nicola Magrini, Roberto D'Amico, Chiara Bassi,[...]. Cochrane Database Syst Rev 2016
53
66

Premature ovarian insufficiency: an International Menopause Society White Paper.
N Panay, R A Anderson, R E Nappi, A J Vincent, S Vujovic, L Webber, W Wolfman. Climacteric 2020
43
66

Duration of menopausal vasomotor symptoms over the menopause transition.
Nancy E Avis, Sybil L Crawford, Gail Greendale, Joyce T Bromberger, Susan A Everson-Rose, Ellen B Gold, Rachel Hess, Hadine Joffe, Howard M Kravitz, Ping G Tepper,[...]. JAMA Intern Med 2015
361
66

Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality: The Women's Health Initiative Randomized Trials.
JoAnn E Manson, Aaron K Aragaki, Jacques E Rossouw, Garnet L Anderson, Ross L Prentice, Andrea Z LaCroix, Rowan T Chlebowski, Barbara V Howard, Cynthia A Thomson, Karen L Margolis,[...]. JAMA 2017
240
33

Pharmacologic and hormonal treatments for menopausal sleep disturbances: A network meta-analysis of 43 randomized controlled trials and 32,271 menopausal women.
Yu-Shian Cheng, Ping-Tao Tseng, Ming-Kung Wu, Yu-Kang Tu, Yi-Cheng Wu, Dian-Jeng Li, Tien-Yu Chen, Kuan-Pin Su, Brendon Stubbs, Andre F Carvalho,[...]. Sleep Med Rev 2021
6
33

Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society.
Wulf H Utian, David F Archer, Gloria A Bachmann, Christopher Gallagher, Francine n Grodstein, Julia R Heiman, Victor W Henderson, Howard N Hodis, Richard H Karas, Rogerio A Lobo,[...]. Menopause 2008
151
33



Hormone therapy for preventing cardiovascular disease in post-menopausal women.
Henry M P Boardman, Louise Hartley, Anne Eisinga, Caroline Main, Marta Roqué i Figuls, Xavier Bonfill Cosp, Rafael Gabriel Sanchez, Beatrice Knight. Cochrane Database Syst Rev 2015
228
33

An overview of dehydroepiandrosterone (EM-760) as a treatment option for genitourinary syndrome of menopause.
Michelle Holton, Chelsea Thorne, Andrew T Goldstein. Expert Opin Pharmacother 2020
10
33



Association between menopausal hormone therapy, mammographic density and breast cancer risk: results from the E3N cohort study.
M Fornili, V Perduca, A Fournier, A Jérolon, M C Boutron-Ruault, G Maskarinec, G Severi, L Baglietto. Breast Cancer Res 2021
2
50

Tibolone in postmenopausal women: a review based on recent randomised controlled clinical trials.
Nicoletta Biglia, Silvia Maffei, Stefano Lello, Rossella E Nappi. Gynecol Endocrinol 2010
41
33

Effects of oral versus transdermal menopausal hormone treatments on self-reported sleep domains and their association with vasomotor symptoms in recently menopausal women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS).
Dahima Cintron, Brian D Lahr, Kent R Bailey, Nanette Santoro, Robin Lloyd, JoAnn E Manson, Genevieve Neal-Perry, Lubna Pal, Hugh S Taylor, Whitney Wharton,[...]. Menopause 2018
23
33

Biologic effects of transdermal estradiol.
R J Chetkowski, D R Meldrum, K A Steingold, D Randle, J K Lu, P Eggena, J M Hershman, N K Alkjaersig, A P Fletcher, H L Judd. N Engl J Med 1986
521
33


Estradiol-based postmenopausal hormone therapy and risk of cardiovascular and all-cause mortality.
Tomi S Mikkola, Pauliina Tuomikoski, Heli Lyytinen, Pasi Korhonen, Fabian Hoti, Pia Vattulainen, Mika Gissler, Olavi Ylikorkala. Menopause 2015
64
33

Differential Effects of Progestogens Used for Menopausal Hormone Therapy.
Kristin VAN Heertum, James Liu. Clin Obstet Gynecol 2018
7
33


The route of administration, timing, duration and dose of postmenopausal hormone therapy and cardiovascular outcomes in women: a systematic review.
Clare Oliver-Williams, Marija Glisic, Sara Shahzad, Elizabeth Brown, Cristina Pellegrino Baena, Mahmuda Chadni, Rajiv Chowdhury, Oscar H Franco, Taulant Muka. Hum Reprod Update 2019
26
33

Hormone Therapy Use and Risk of Chronic Disease in the Nurses' Health Study: A Comparative Analysis With the Women's Health Initiative.
Shilpa N Bhupathiraju, Francine Grodstein, Bernard A Rosner, Meir J Stampfer, Frank B Hu, Walter C Willett, JoAnn E Manson. Am J Epidemiol 2017
17
33


Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes.
A H Maclennan, J L Broadbent, S Lester, V Moore. Cochrane Database Syst Rev 2004
285
33


TX-001HR is associated with a clinically meaningful effect on severity of moderate to severe vasomotor symptoms in the REPLENISH trial.
Ginger D Constantine, James A Simon, Andrew M Kaunitz, James H Pickar, Dennis A Revicki, Shelli Graham, Brian Bernick, Sebastian Mirkin. Menopause 2020
1
100

The testosterone prescribing practice of BMS menopause specialists.
A Scott, D Holloway, J Rymer, D Bruce. Post Reprod Health 2021
2
50

Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol.
Howard N Hodis, Wendy J Mack, Victor W Henderson, Donna Shoupe, Matthew J Budoff, Juliana Hwang-Levine, Yanjie Li, Mei Feng, Laurie Dustin, Naoko Kono,[...]. N Engl J Med 2016
338
33

Bremelanotide and flibanserin for low sexual desire in women: the fallacy of regulatory precedent.
Barbara Mintzes, Leonore Tiefer, Lisa Cosgrove. Drug Ther Bull 2021
1
100


Randomized Controlled Phase II Evaluation of Two Dose Levels of Bupropion Versus Placebo for Sexual Desire in Female Cancer Survivors: NRG-CC004.
Debra L Barton, Stephanie L Pugh, Patricia A Ganz, Steven C Plaxe, Bridget F Koontz, Jeanne Carter, Natalya Greyz-Yusupov, Seth J Page, Kendrith M Rowland, Ernie P Balcueva,[...]. J Clin Oncol 2022
4
33

Efficacy and Safety of Flibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Women: A Systematic Review and Meta-analysis.
Loes Jaspers, Frederik Feys, Wichor M Bramer, Oscar H Franco, Peter Leusink, Ellen T M Laan. JAMA Intern Med 2016
96
33

Increased risk of recurrence after hormone replacement therapy in breast cancer survivors.
Lars Holmberg, Ole-Erik Iversen, Carl Magnus Rudenstam, Mats Hammar, Eero Kumpulainen, Janusz Jaskiewicz, Jacek Jassem, Daria Dobaczewska, Hans E Fjosne, Octavio Peralta,[...]. J Natl Cancer Inst 2008
162
33



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.